Natera Inc (NTRA) : Jasper Ridge Partners reduced its stake in Natera Inc by 33.09% during the most recent quarter end. The investment management company now holds a total of 21,574 shares of Natera Inc which is valued at $250,258 after selling 10,669 shares in Natera Inc , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Natera Inc makes up approximately 0.02% of Jasper Ridge Partners’s portfolio.
Other Hedge Funds, Including , Tudor Investment Corp Et Al sold out all of its stake in NTRA during the most recent quarter. The investment firm sold 10,321 shares of NTRA which is valued $119,724.Blackrock Group Ltd boosted its stake in NTRA in the latest quarter, The investment management firm added 6,218 additional shares and now holds a total of 16,744 shares of Natera Inc which is valued at $150,696.Blackrock Investment Management reduced its stake in NTRA by selling 244 shares or 0.26% in the most recent quarter. The Hedge Fund company now holds 95,297 shares of NTRA which is valued at $857,673.Blackrock Fund Advisors boosted its stake in NTRA in the latest quarter, The investment management firm added 45,776 additional shares and now holds a total of 664,048 shares of Natera Inc which is valued at $5,976,432.
Natera Inc opened for trading at $11.9 and hit $11.99 on the upside on Monday, eventually ending the session at $11.98, with a gain of 0.59% or 0.07 points. The heightened volatility saw the trading volume jump to 2,50,520 shares. Company has a market cap of $628 M.
On the company’s financial health, Natera Inc reported $-0.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Nov 9, 2016. Analyst had a consensus of $-0.56. The company had revenue of $53.89 million for the quarter, compared to analysts expectations of $48.27 million. The company’s revenue was up 20.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.39 EPS.
Many Wall Street Analysts have commented on Natera Inc. Company shares were Reiterated by The Benchmark Company on Nov 10, 2016 to “Buy”, Firm has raised the Price Target to $ 20 from a previous price target of $16 .
Natera Inc. is a diagnostics company. The Company has molecular and bioinformatics technology that it deploys to change genetic diseases across the world. Its molecular assays measure various regions across the genome from samples as small as a single cell. Its statistical algorithms combine these measurements with the available data to detect a range of serious conditions. It is engaged in developing products for various oncology applications. In addition to its direct sales force in the United States the Company has a global network of over 70 laboratory and distribution partners. It has introduced a cloud-based distribution model. It also has launched seven molecular diagnostic tests. The Company launched Panorama which is its non-invasive prenatal test (NIPT). Its products include Pre-implantation Genetic Screening Pre-implantation Genetic Diagnosis Products of Conception Non-Invasive Paternity Testing High Throughput Carrier Screening and Non-Invasive Prenatal Testing.